A heme oxygenase-1 transducer model of degenerative and developmental brain disorders

International Journal of Molecular Sciences

Volumn 16, Issue 3, 2015, Pages 5400-5419

  Schipper, Hyman M ^a,b   Song, Wei ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Alzheimer disease; Astrocyte; Carbon monoxide; Heme oxygenase 1; Iron; Macroautophagy; Mitochondria; Oxidative stress; Parkinson disease; Schizophrenia

Indexed keywords

HEME OXYGENASE 1; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; IRON;

ALZHEIMER DISEASE; ASTROCYTE; CHRONIC BRAIN DISEASE; DEGENERATIVE DISEASE; DEVELOPMENTAL DISORDER; GENE MUTATION; HUMAN; IMMUNOREACTIVITY; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; UPREGULATION; ANIMAL; GENETICS; METABOLISM;

ALZHEIMER DISEASE; ANIMALS; HEME OXYGENASE-1; HUMANS; IRON; PARKINSON DISEASE; SIGNAL TRANSDUCTION;

EID: 84925862799     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16035400     Document Type: Review

References (90)

1. Schipper, H.M. Brain iron deposition and the free radical-mitochondrial theory of ageing. Ageing Res. Rev. 2004, 3, 265–301.
2. Selkoe, D.J. The molecular pathology of alzheimer’s disease. Neuron 1991, 6, 487–498.
3. Corral-Debrinski, M.; Horton, T.; Lott, M.T.; Shoffner, J.M.; McKee, A.C.; Beal, M.F.; Graham, B.H.; Wallace, D.C. Marked changes in mitochondrial DNA deletion levels in alzheimer brains. Genomics 1994, 23, 471–476.
4. Tanno, Y.; Okuizumi, K.; Tsuji, S. Mtdna polymorphisms in japanese sporadic alzheimer’s disease. Neurobiol. Aging 1998, 19, S47–S51.
5. Bonilla, E.; Tanji, K.; Hirano, M.; Vu, T.H.; DiMauro, S.; Schon, E.A. Mitochondrial involvement in alzheimer’s disease. Biochim. Biophys. Acta 1999, 1410, 171–182.
6. Gibson, G.E.; Sheu, K.F.; Blass, J.P. Abnormalities of mitochondrial enzymes in alzheimer disease. J. Neural Transm. 1998, 105, 855–870.
7. Hirai, K.; Aliev, G.; Nunomura, A.; Fujioka, H.; Russell, R.L.; Atwood, C.S.; Johnson, A.B.; Kress, Y.; Vinters, H.V.; Tabaton, M, et al. Mitochondrial abnormalities in alzheimer’s disease. J. Neurosci. 2001, 21, 3017–3023.
8. Minoshima, S.; Giordani, B.; Berent, S.; Frey, K.A.; Foster, N.L.; Kuhl, D.E. Metabolic reduction in the posterior cingulate cortex in very early alzheimer’s disease. Ann. Neurol. 1997, 42, 85–94.
9. Fukuyama, H.; Ogawa, M.; Yamauchi, H.; Yamaguchi, S.; Kimura, J.; Yonekura, Y.; Konishi, J. Altered cerebral energy metabolism in alzheimer’s disease: A pet study. J. Nucl. Med. 1994, 35, 1–6.
10. Butterfield, D.A. Amyloid β-peptide (1–42)-induced oxidative stress and neurotoxicity: Implications for neurodegeneration in alzheimer’s disease brain. A review. Free Radic. Res. 2002, 36, 1307–1313.
11. McGeer, P.L.; McGeer, E.G. The inflammatory response system of brain: Implications for therapy of alzheimer and other neurodegenerative diseases. Brain Res. Brain Res. Rev. 1995, 21, 195–218.
12. Schipper, H.M. Glial iron sequestration and neurodegeneration. In Astrocytes in Brain Aging and Neurodegeneration; Schipper, H.M., Ed.; R.G. Landes Co.: Austin, TX, USA, 1998; pp. 235–251.
13. Sayre, L.M.; Smith, M.A.; Perry, G. Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr. Med. Chem. 2001, 8, 721–738.
14. Schipper, H.M. Glial HO-1 expression, iron deposition and oxidative stress in neurodegenerative diseases. Neurotox. Res. 1999, 1, 57–70.
15. Cheung, Z.H.; Ip, N.Y. The emerging role of autophagy in parkinson’s disease. Mol. Brain 2009, 2, 29.
16. Jenner, P. Oxidative stress in parkinson’s disease. Ann. Neurol. 2003, S26–S38.
17. Hattori, N.; Tanaka, M.; Ozawa, T.; Mizuno, Y. Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in parkinson’s disease. Ann. Neurol. 1991, 30, 563–571.
18. Storm, T.; Rath, S.; Mohamed, S.A.; Bruse, P.; Kowald, A.; Oehmichen, M.; Meissner, C. Mitotic brain cells are just as prone to mitochondrial deletions as neurons: A large-scale single-cell PCR study of the human caudate nucleus. Exp. Gerontol. 2002, 37, 1389–1400.
19. Bowen, B.C.; Block, R.E.; Sanchez-Ramos, J.; Pattany, P.M.; Lampman, D.A.; Murdoch, J.B.; Quencer, R.M. Proton MR spectroscopy of the brain in 14 patients with parkinson disease. Am. J. Neuroradiol. 1995, 16, 61–68.
20. Prabakaran, S.; Swatton, J.E.; Ryan, M.M.; Huffaker, S.J.; Huang, J.T.; Griffin, J.L.; Wayland, M.; Freeman, T.; Dudbridge, F.; Lilley, K.S, et al. Mitochondrial dysfunction in schizophrenia: Evidence for compromised brain metabolism and oxidative stress. Mol. Psychiatry 2004, 9, 684–697.
21. Casanova, M.F.; Comparini, S.O.; Kim, R.W.; Kleinman, J.E. Staining intensity of brain iron in patients with schizophrenia: A postmortem study. J. Neuropsychiatry Clin. Neurosci. 1992, 4, 36–41.
22. Kolomeets, N.S.; Uranova, N. Ultrastructural abnormalities of astrocytes in the hippocampus in schizophrenia and duration of illness: A postortem morphometric study. World J. Biol. Psychiatry 2010, 11, 282–292.
23. Ryter, S.W.; Tyrrell, R.M. The heme synthesis and degradation pathways: Role in oxidant sensitivity. Heme oxygenase has both pro- and antioxidant properties. Free Radic. Biol. Med. 2000, 28, 289–309.
24. Scapagnini, G.; D'Agata, V.; Calabrese, V.; Pascale, A.; Colombrita, C.; Alkon, D.; Cavallaro, S. Gene expression profiles of heme oxygenase isoforms in the rat brain. Brain Res. 2002, 954, 51–59.
25. Baranano, D.E.; Snyder, S.H. Neural roles for heme oxygenase: Contrasts to nitric oxide synthase. Proc. Natl. Acad. Sci. USA 2001, 98, 10996–11002.
26. Verma, A.; Hirsch, D.J.; Glatt, C.E.; Ronnett, G.V.; Snyder, S.H. Carbon monoxide: A putative neural messenger. Science 1993, 259, 381–384.
27. Schipper, H.M.; Song, W.; Zukor, H.; Hascalovici, J.R.; Zeligman, D. Heme oxygenase-1 and neurodegeneration: Expanding frontiers of engagement. J. Neurochem. 2009, 110, 469–485.
28. Ryter, S.W.; Alam, J.; Choi, A.M. Heme oxygenase-1/carbon monoxide: From basic science to therapeutic applications. Physiol. Rev. 2006, 86, 583–650.
29. Stocker, R.; Yamamoto, Y.; McDonagh, A.F.; Glazer, A.N.; Ames, B.N. Bilirubin is an antioxidant of possible physiological importance. Science 1987, 235, 1043–1046.
30. Nakagami, T.; Toyomura, K.; Kinoshita, T.; Morisawa, S. A beneficial role of bile pigments as an endogenous tissue protector: Anti-complement effects of biliverdin and conjugated bilirubin. Biochim. Biophys. Acta 1993, 1158, 189–193.
31. Llesuy, S.F.; Tomaro, M.L. Heme oxygenase and oxidative stress. Evidence of involvement of bilirubin as physiological protector against oxidative damage. Biochim. Biophys. Acta 1994, 1223, 9–14.
32. Dore, S.; Takahashi, M.; Ferris, C.D.; Zakhary, R.; Hester, L.D.; Guastella, D.; Snyder, S.H. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc. Natl. Acad. Sci. USA 1999, 96, 2445–2450.
33. Dennery, P.A. Regulation and role of heme oxygenase in oxidative injury. Curr. Top. Cell. Regul. 2000, 36, 181–199.
34. Piantadosi, C.A.; Carraway, M.S.; Suliman, H.B. Carbon monoxide, oxidative stress, and mitochondrial permeability pore transition. Free Radic. Biol. Med. 2006, 40, 1332–1339.
35. Frankel, D.; Mehindate, K.; Schipper, H.M. Role of heme oxygenase-1 in the regulation of manganese superoxide dismutase gene expression in oxidatively-challenged astroglia. J. Cell. Physiol. 2000, 185, 80–86.
36. Hirose, W.; Ikematsu, K.; Tsuda, R. Age-associated increases in heme oxygenase-1 and ferritin immunoreactivity in the autopsied brain. Leg Med. (Tokyo) 2003, 5, S360–S366.
37. Song, W.; Zukor, H.; Liberman, A.; Kaduri, S.; Arvanitakis, Z.; Bennett, D.A.; Schipper, H.M. Astroglial heme oxygenase-1 and the origin of corpora amylacea in aging and degenerating neural tissues. Exp. Neurol. 2014, 254, 78–89.
38. Barone, E.; di Domenico, F.; Mancuso, C.; Butterfield, D.A. The Janus face of the heme oxygenase/biliverdin reductase system in alzheimer disease: It’s time for reconciliation. Neurobiol. Dis. 2013, 62C, 144–159.
39. Barone, E.; di Domenico, F.; Sultana, R.; Coccia, R.; Mancuso, C.; Perluigi, M.; Butterfield, D.A. Heme oxygenase-1 posttranslational modifications in the brain of subjects with alzheimer disease and mild cognitive impairment. Free Radic. Biol. Med. 2012, 52, 2292–2301.
40. Schipper, H.M.; Liberman, A.; Stopa, E.G. Neural heme oxygenase-1 expression in idiopathic parkinson’s disease. Exp. Neurol. 1998, 150, 60–68.
41. Schipper, H.M. Heme oxygenase expression in human central nervous system disorders. Free Radic. Biol. Med. 2004, 37, 1995–2011.
42. Ham, D.; Schipper, H.M. Heme oxygenase-1 induction and mitochondrial iron sequestration in astroglia exposed to amyloid peptides. Cell. Mol. Biol. 2000, 46, 587–596.
43. Mehindate, K.; Sahlas, D.J.; Frankel, D.; Mawal, Y.; Liberman, A.; Corcos, J.; Dion, S.; Schipper, H.M. Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: Implications for multiple sclerosis. J. Neurochem. 2001, 77, 1386–1395.
44. Schipper, H.M.; Bernier, L.; Mehindate, K.; Frankel, D. Mitochondrial iron sequestration in dopamine-challenged astroglia: Role of heme oxygenase-1 and the permeability transition pore. J. Neurochem. 1999, 72, 1802–1811.
45. Song, W.; Su, H.; Song, S.; Paudel, H.K.; Schipper, H.M. Over-expression of heme oxygenase-1 promotes oxidative mitochondrial damage in rat astroglia. J. Cell. Physiol. 2006, 206, 655–663.
46. Vaya, J.; Song, W.; Khatib, S.; Geng, G.; Schipper, H.M. Effects of heme oxygenase-1 expression on sterol homeostasis in rat astroglia. Free Radic. Biol. Med. 2007, 42, 864–871.
47. Bernier, L.; Bernatchez, G.; Schipper, H. In Oxidative Stress Promotes Mitochondrial Iron Sequestration in Cultured Astroglia; Psychology Press: London, UK, 1996; p. 1495.
48. McLaren, J.; Brawer, J.R.; Schipper, H.M. Iron content correlates with peroxidase activity in cysteamine-induced astroglial organelles. J. Histochem. Cytochem. 1992, 40, 1887–1897.
49. Zukor, H.; Song, W.; Liberman, A.; Mui, J.; Vali, H.; Fillebeen, C.; Pantopoulos, K.; Wu, T.D.; Guerquin-Kern, J.L.; Schipper, H.M. Ho-1-mediated macroautophagy: A mechanism for unregulated iron deposition in aging and degenerating neural tissues. J. Neurochem. 2009, 109, 776–791.
50. Bernardi, P. The permeability transition pore. Control points of a cyclosporin a-sensitive mitochondrial channel involved in cell death. Biochim. Biophys. Acta 1996, 1275, 5–9.
51. Petronilli, V.; Cola, C.; Massari, S.; Colonna, R.; Bernardi, P. Physiological effectors modify voltage sensing by the cyclosporin A-sensitive permeability transition pore of mitochondria. J. Biol. Chem. 1993, 268, 21939–21945.
52. Linnane, A.W.; Zhang, C.; Baumer, A.; Nagley, P. Mitochondrial DNA mutation and the ageing process: Bioenergy and pharmacological intervention. Mutat. Res. 1992, 275, 195–208.
53. Chopra, V.S.; Moozar, K.L.; Mehindate, K.; Schipper, H.M. A cellular stress model for the differential expression of glial lysosomal cathepsins in the aging nervous system. Exp. Neurol. 1997, 147, 221–228.
54. Schipper, H.M.; Cissé, S. Mitochondrial constituents of corpora amylacea and autofluorescent astrocytic inclusions in senescent human brain. Glia 1995, 14, 55–64.
55. Cavanagh, J.B. Corpora-amylacea and the family of polyglucosan diseases. Brain Res. Brain Res. Rev. 1999, 29, 265–295.
56. Lin, Q.; Weis, S.; Yang, G.; Weng, Y.H.; Helston, R.; Rish, K.; Smith, A.; Bordner, J.; Polte, T.; Gaunitz, F, et al. Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress. J. Biol. Chem. 2007, 282, 20621–20633.
57. Song, L.; Song, W.; Schipper, H.M. Astroglia overexpressing heme oxygenase-1 predispose co-cultured PC12 cells to oxidative injury. J. Neurosci. Res. 2007, 85, 2186–2195.
58. Schipper, H.M.; Kotake, Y.; Janzen, E.G. Catechol oxidation by peroxidase-positive astrocytes in primary culture: An electron spin resonance study. J. Neurosci. 1991, 11, 2170–2176.
59. Schipper, H.M. Mitochondrial iron deposition in aging astroglia: Mechanisms and disease implications. In Mitochondrial Ubiquinone (Coenzyme Q): Biochemical, Functional, Medical, and Therapeutic Aspects in Human Health And Disease; Ebadi, M.J., Chopra, R.K., Eds.; Prominent Press: Shepparton, Austria, 2001; pp. 267–280.
60. Di Monte, D.A.; Schipper, H.M.; Hetts, S.; Langston, J.W. Iron-mediated bioactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in glial cultures. Glia 1995, 15, 203–206.
61. Kontos, H.A.; Wei, E.P.; Ellis, E.F.; Jenkins, L.W.; Povlishock, J.T.; Rowe, G.T.; Hess, M.L. Appearance of superoxide anion radical in cerebral extracellular space during increased prostaglandin synthesis in cats. Circ. Res. 1985, 57, 142–151.
62. Hascalovici, J.R.; Song, W.; Vaya, J.; Khatib, S.; Fuhrman, B.; Aviram, M.; Schipper, H.M. Impact of heme oxygenase-1 on cholesterol synthesis, cholesterol efflux and oxysterol formation in cultured astroglia. J. Neurochem. 2009, 108, 72–81.
63. Hascalovici, J.R, Vaya, J, Khatib, S, Holcroft, C.A, Zukor, H, Song, W, Arvanitakis, Z, Bennett, D.A, Schipper, H.M. Brain sterol dysregulation in sporadic ad and mci: Relationship to heme oxygenase- 1. J. Neurochem. 2009, 110, 1241–1253.
64. Song, W.; Patel, A.; Qureshi, H.Y.; Han, D.; Schipper, H.M.; Paudel, H.K. The parkinson disease-associated a30p mutation stabilizes alpha-synuclein against proteasomal degradation triggered by heme oxygenase-1 over-expression in human neuroblastoma cells. J. Neurochem. 2009, 110, 719–733.
65. Song, W.; Zukor, H.; Lin, S.H.; Hascalovici, J.; Liberman, A.; Tavitian, A.; Mui, J.; Vali, H.; Tong, X.K.; Bhardwaj, S.K, et al. Schizophrenia-like features in transgenic mice overexpressing human ho-1 in the astrocytic compartment. J. Neurosci. 2012, 32, 10841–10853.
66. Song, W.; Zukor, H.; Lin, S.H.; Liberman, A.; Tavitian, A.; Mui, J.; Vali, H.; Fillebeen, C.; Pantopoulos, K.; Wu, T.D, et al. Unregulated brain iron deposition in transgenic mice over-expressing hmox1 in the astrocytic compartment. J. Neurochem. 2012, 123, 325–336.
67. Brown, A.S. The environment and susceptibility to schizophrenia. Prog. Neurobiol. 2011, 93, 23–58.
68. King, S.; St-Hilaire, A.; Heidkamp, D. Prenatal factors in schizophrenia. Curr. Dir. Psychol. Sci. 2010, 19, 209–213.
69. Wilson, C.; Terry, A.V., Jr. Neurodevelopmental animal models of schizophrenia: Role in novel drug discovery and development. Clin. Schizophr. Relat. Psychoses 2010, 4, 124–137.
70. Song, W.; Liberman, A.; Schipper, H.M. Parkinsonian features in aging GFAP. Hmox1 transgenic mice overexpressing human HO-1 in the astroglial compartment. J. Parkinsons Dis. 2013, 3, 69–69.
71. Gupta, A.; Lacoste, B.; Pistel, P.J.; Ingram, D.K.; Hamel, E.; Alaoui-Jamali, M.A.; Szarek, W.A.; Vlahakis, J.Z.; Jie, S.; Song, W, et al. Neurotherapeutic effects of novel ho-1 inhibitors in vitro and in a transgenic mouse model of alzheimer’s disease. J. Neurochem. 2014, 131, 778–790.
72. Hui, Y.; Wang, D.; Li, W.; Zhang, L.; Jin, J.; Ma, N.; Zhou, L.; Nakajima, O.; Zhao, W.; Gao, X. Long-term overexpression of heme oxygenase 1 promotes tau aggregation in mouse brain by inducing tau phosphorylation. J. Alzheimers Dis. 2011, 26, 299–313.
73. Kirkwood, T.B.; Rose, M.R. Evolution of senescence: Late survival sacrificed for reproduction. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1991, 332, 15–24.
74. Williams, G.C. Pleiotropy, natural selection, and the evolution of senescence. Evolution 1957, 11, 398–411.
75. Drummond, G.S.; Kappas, A. Chemoprevention of severe neonatal hyperbilirubinemia. Semin. Perinatol. 2004, 28, 365–368.
76. Kappas, A.; Drummond, G.S.; Galbraith, R.A. Prolonged clinical use of a heme oxygenase inhibitor: Hematological evidence for an inducible but reversible iron-deficiency state. Pediatrics 1993, 91, 537–539.
77. Alaoui-Jamali, M.A.; Bismar, T.A.; Gupta, A.; Szarek, W.A.; Su, J.; Song, W.; Xu, Y.; Xu, B.; Liu, G.; Vlahakis, J.Z, et al. A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer. Cancer Res. 2009, 69, 8017–8024.
78. Rozema, D.B.; Lewis, D.L.; Wakefield, D.H.; Wong, S.C.; Klein, J.J.; Roesch, P.L.; Bertin, S.L.; Reppen, T.W.; Chu, Q.; Blokhin, A.V, et al. Dynamic polyconjugates for targeted in vivo delivery of sirna to hepatocytes. Proc. Natl. Acad. Sci. USA 2007, 104, 12982–12987.
79. Kumar, P.; Wu, H.; McBride, J.L.; Jung, K.E.; Kim, M.H.; Davidson, B.L.; Lee, S.K.; Shankar, P.; Manjunath, N. Transvascular delivery of small interfering rna to the central nervous system. Nature 2007, 448, 39–43.
80. Syapin, P.J. Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders. Br. J. Pharmacol. 2008, 155, 623–640.
81. Le, W.D.; Xie, W.J.; Appel, S.H. Protective role of heme oxygenase-1 in oxidative stress-induced neuronal injury. J. Neurosci. Res. 1999, 56, 652–658.
82. Takeda, A.; Perry, G.; Abraham, N.G.; Dwyer, B.E.; Kutty, R.K.; Laitinen, J.T.; Petersen, R.B.; Smith, M.A. Overexpression of heme oxygenase in neuronal cells, the possible interaction with TAU. J. Biol. Chem. 2000, 275, 5395–5399.
83. Maines, M.D.; Polevoda, B.; Coban, T.; Johnson, K.; Stoliar, S.; Huang, T.J.; Panahian, N.; Cory-Slechta, D.A.; McCoubrey, W.K., Jr. Neuronal overexpression of heme oxygenase-1 correlates with an attenuated exploratory behavior and causes an increase in neuronal nadph diaphorase staining. J. Neurochem. 1998, 70, 2057–2069.
84. Chen, K.; Gunter, K.; Maines, M.D. Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death. J. Neurochem. 2000, 75, 304–313.
85. Panahian, N.; Yoshiura, M.; Maines, M.D. Overexpression of heme oxygenase-1 is neuroprotective in a model of permanent middle cerebral artery occlusion in transgenic mice. J. Neurochem. 1999, 72, 1187–1203.
86. Fukuda, K.; Richmon, J.D.; Sato, M.; Sharp, F.R.; Panter, S.S.; Noble, L.J. Induction of heme oxygenase-1 (HO-1) in glia after traumatic brain injury. Brain Res. 1996, 736, 68–75.
87. Lin, Y.; Vreman, H.J.; Wong, R.J.; Tjoa, T.; Yamauchi, T.; Noble-Haeusslein, L.J. Heme oxygenase-1 stabilizes the blood-spinal cord barrier and limits oxidative stress and white matter damage in the acutely injured murine spinal cord. J. Cereb. Blood Flow Metab. 2007, 27, 1010–1021.
88. Ahmad, A.S.; Zhuang, H.; Dore, S. Heme oxygenase-1 protects brain from acute excitotoxicity. Neuroscience 2006, 141, 1703–1708.
89. Huang, E.; Ong, W.Y.; Go, M.L.; Garey, L.J. Heme oxygenase-1 activity after excitotoxic injury: Immunohistochemical localization of bilirubin in neurons and astrocytes and deleterious effects of heme oxygenase inhibition on neuronal survival after kainate treatment. J. Neurosci. Res. 2005, 80, 268–278.
90. Hascalovici, J.R.; Song, W.; Liberman, A.; Vaya, J.; Khatib, S.; Holcroft, C.; Laferla, F.; Schipper, H.M. Neural ho-1/sterol interactions in vivo: Implications for alzheimer’s disease. Neuroscience 2014, 280C, 40–49.